re: market excited The lack of details is impacting the share...

re: market excited The lack of details is impacting the share price. However something can be gained from the following quote from J "We had a rational plan of starting modestly and gradually stepping up in value to create some momentum. Then we went to the United States and licensed Nanogen, for a $250,000 one-time payment. Then came Sequenom ($500,000), Perlegen ($860,000), and then Myriad (more than $1 million)."

None of these took gtg to court and I don't think Jacobson is too happy with Applera. However it did provide a test case that was being watched by many companies.

There are also a number of other companies waiting for the results to be out before "rolling over". These will be announced soon and this will impact the share price in a big way.

Also:

Probably all of the current investors were expecting a positive announcement.

Many of the current investors may be traders waiting until the announcement was out to sell at a higher price. Note the volume. They expected the price to go up but because of the volume of traders selling and the lack of details the price has barely moved. They are moving out.

Expect other announcements out very soon.

G